Sickle Cell Gene Cures Face Cost Hurdles
New gene therapies can cure sickle cell disease, but high prices and slow rollouts keep patients waiting.
Millions of people live with sickle cell disease. It brings sudden pain, and it damages the body over time. Now scientists have a cure. New gene therapies fix the broken cells inside the blood.
The FDA approved these treatments last year. Doctors praise the science behind them. Yet, few patients receive the care today. Each treatment costs millions of dollars. Insurance companies take months to pay those bills.
Hospitals also face limits. Only special medical centers can handle this complex care. Patients must travel far from home, and the process requires long hospital stays.
Medical progress takes time to reach the public. Companies that lower production costs will win big markets. Watch for biotech firms that make these cures cheaper and easier to deliver.
Source: CNBC
More from Biotech
